— Know what they know.
Not Investment Advice

ZOTA.NS NSE

Zota Health Care Limited
1W: -5.8% 1M: +23.3% 3M: -12.3% YTD: -8.7% 1Y: -5.3% 3Y: +212.0% 5Y: +412.2%
₹1,310.00 ($13.61)
+42.20 (+3.33%)
 
NSE · Healthcare · Biotechnology · Tech Score Buy · Power 67 · ₹38.0B mcap · 9M float · 1.03% daily turnover

Income Trends

Revenue
$5.4B +83.9% ▲
5Y CAGR: +38.2%
Gross Profit
$639M -58.9% ▼
5Y CAGR: +27.0%
Operating Income
-$639M -30.6% ▼
Net Income
-$739M -31.1% ▼
EPS (Diluted)
$-22.46 -9.4% ▼
EBITDA
$185M +605.9% ▲
5Y CAGR: +45.3%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$1.3B$1.4B$1.8B$2.9B$5.4B
YoY Growth+22.9%+6.7%+29.0%+62.3%+83.9%
Cost of Revenue$893M$1.1B$1.0B$1.4B$4.7B
Gross Profit$419M$311M$803M$1.6B$639M
Gross Margin31.9%22.2%44.5%53.1%11.9%
R&D Expenses$600K$600K$7K$2K$0
SG&A Expenses$160M$341M$413M$753M$1.3B
Operating Expenses$307M$350M$930M$2.0B$1.3B
Operating Income$112M-$45M-$126M-$489M-$639M
Operating Margin8.5%-3.2%-7.0%-16.7%-11.9%
Interest Expense$3M$26M$48M$108M$174M
Income Before Tax$124M-$47M-$162M-$576M-$798M
Tax Expense$35M$11M-$18M-$9M-$58M
Net Income$89M-$58M-$143M-$564M-$739M
Net Margin6.8%-4.1%-7.9%-19.3%-13.7%
EPS (Diluted)$3.58$-2.29$-5.55$-20.53$-22.46
EBITDA$164M$98M$81M-$37M$185M
Shares Outstanding25M25M26M27M33M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms